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Background: WHO has set a goal of 75% vaccination coverage (VC) for seasonal influenza for residents and also
recommends immunization for all healthcare workers (HCWs) in nursing homes (NHs). We conducted a cross-sectional
study to estimate the VC for seasonal influenza vaccination in Norwegian NHs in 2012/2013 since the VC in NHs and
HCWs is unknown.
Methods: We gathered information from NHs concerning VC for residents and HCWs, and vaccination costs for
HCWs, using a web-based questionnaire. We calculated VC among NH residents by dividing the number of residents
vaccinated by the total number of residents for each NH. VC among HCWs was similarly calculated by dividing the
number of HCWs vaccinated by the total number of HCWs for each NH. The association between VC and possible
demographic variables were explored.
Results: Of 910 NHs, 354 (38.9%) responded. Median VC per NH was 71.7% (range 0-100) among residents and 0%
(range 0-100) among HCWs, with 214 (60%) NHs reporting that none of their HCWs was vaccinated. Median VC for
HCWs in NHs with an annual vaccination campaign was 0% (range 0-53), compared to when they did not have an
annual vaccination campaign 0% (range 0-12); the distributions in the two groups differed significantly (Mann–Whitney
U, P = 0.006 two tailed).
Conclusion: Median influenza VC in Norwegian NHs was marginally lower than recommended among residents and
exceptionally low among HCWs. The VC in HCWs was significantly higher when NHs had an annual vaccination
campaign. We recommend that NHs implement measures to increase VC among residents and HCWs, including
vaccination campaigns and studies to identify potential barriers to vaccination.Background
Residents in nursing homes (NHs) and long-term care
facilities (LTCF) are at higher risk of severe respiratory
tract infections owing to old age, the number of under-
lying illnesses, and close living conditions [1-3]. The
main vaccine- preventable respiratory tract infection is
caused by the influenza virus. The infection can be* Correspondence: horst.bentele@fhi.no
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unless otherwise stated.severe and even lethal, and viral infections often predis-
pose sufferers to bacterial secondary infections and
complications [4]. Further, although the lethality of in-
fluenza infection is low, the resulting reduced general
condition following infection is of major importance in
the elderly. Accordingly, the World Health Organization
(WHO) defines NHs residents as a risk group for severe
influenza and recommends vaccination coverage (VC) of
at least 75%. The main goals are to reduce risk of severe
disease and to prevent outbreaks. The WHO recommen-
dation also includes influenza vaccination of health care
workers (HCWs) in order to prevent introduction of the
disease into healthcare institutions [5,6]. The Norwegian
guidelines for infectious disease control follow the WHOLtd. This is an Open Access article distributed under the terms of the Creative
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being to achieve a minimum VC of 75% in Norwegian
NHs [7]. Seasonal influenza vaccination for residents in
NHs is reimbursed by the state in Norway. This is in con-
trast to influenza vaccination of HCWs, for whom each
employer decides whether it is to be given free of charge.
The yearly influenza vaccination is normally conducted
during October and November [7].
The Vaccine European New Integrated Collaboration
Effort (VENICE) report, covering the 2011/2012 season,
showed seasonal influenza VC for the general Norwegian
population above 65 years and for all HCWs to be 36%
and 12% respectively [8]. However, the VC among resi-
dents and HCWs in NHs is unknown. To guide develop-
ment of vaccination programs for residents and HCWs
in NHs, data on VC is crucial. We therefore conducted
a cross-sectional study approaching all NHs in Norway
in order to estimate VC for seasonal influenza vaccine
among both residents and HCWs. In addition, we in-
vestigated whether there was an association between
VC and response rate by county, yearly vaccination
campaigns among residents and HCWs, free-of-charge
vaccination of HCWs, NH size (number of residents)
and geographic location.
Methods
Population and data collection
In December 2012 we invited NH managers and NH
physicians to participate in an electronic survey. The in-
vitation was sent to all 429 municipalities in Norway
with the instruction to forward the e-mail to all the NHs
located in the respective municipality. After six weeks a
reminder was sent to the same e-mail-addresses. The
total number of residents in NHs in the different coun-
ties was obtained from Statistics Norway [9]. In 2011,
910 NHs with a total of 34,795 long-term-care residents
were registered in Norway.
The questionnaire (Additional file 1) was developed in
QuestBack to collect aggregated data from each NH.
The questionnaire contained 10 closed questions regard-
ing seasonal influenza vaccination of residents and
HCWs. We also collected general information from the
NHs, including geographic location, number of long-
term-care residents, number of personnel working in
direct contact with the residents, whether influenza
vaccination of HCWs was given free of charge and, if
not, how much personnel had to pay, and if the NHs
had annual vaccination campaigns.
Definitions and data analyses
In Norway, a NH is defined as residential facilities for
elderly people with the primary purpose of providing a
continuous 24-hour professional health-care service. In
this study we only included long-term-care residentswith registered home address at the NHs, since their med-
ical service, including vaccination, is provided by the NH.
We defined a resident as a person with registered home
address at the NH. We defined an HCW as an employee
at an NH who has regular physical contact with the
residents. This includes doctors, nurses, auxiliary nurses,
occupational therapists, physiotherapists, and students.
VC among NH residents was calculated by dividing
the number of residents vaccinated by the total number
of residents for each NH. Similarly, VC among HCWs was
calculated by dividing the number of HCWs vaccinated by
the total number of HCWs for each NH, thereby defining
NH as unit of analysis. VC is presented as median per
county to avoid revealing the NH identity on a municipal-
ity level. We compared the VC between NHs where
HCWs had to pay for their vaccination and those who got
it for free using a Mann-Whitney U-test. Similarly, we
compared the VC in both residents and HCWs in NHs
who had an annual vaccination campaign and those who
did not. Further associations were examined by correlation
analyses (Spearman rank test). The statistical analyses
were done in Excel 2010 and Stata12. A p-value ≤ 0.05 was
considered significant [10].
All data collected were aggregated. Complete anonym-
ity for persons and NHs was given and therefore ethical
approval in Norway not mandated. Participation in the
study was voluntary.
Results
How many of the 910 NHs actually received the invita-
tion is unknown since distribution was by means of gen-
eric municipality e-mail addresses. However, 391 of the
intended 910 invitees in Norway (43.0%) responded to
our survey. We excluded 37 NHs on the basis of incom-
plete data; thus 354 (38.9%) NHs were included in the
analysis. These 354 NHs were located in 244 (57%) of
the 429 municipalities in Norway, with representatives
from all 19 counties. The response rate by county
ranged from 26.7% in Buskerud to 65.5% in Finnmark
(Table 1).
The 354 NHs included in the study provided aggregated
information on a total of 14,208 residents and 28,237
HCWs. The median number of long-term-care residents
per NH was 33 (range 1-168). The median number of
HCWs per NH was 60 (range 15-400). The high number
of HCWs is explained by the fact that we included aggre-
gated data about all NH HCWs in our survey, independ-
ent of NH department, since they usually rotate and hence
work both in long- and short-term-care.
Seasonal influenza vaccination coverage
In the season 2012/13, 54% of the NHs had a VC among
residents below 75% and in 15% of NHs VC among resi-
dents was below 50% (Figure 1), the median VC being
Table 1 Response rate and vaccination coverage (VC) among long-term-care residents and HCWs of the responding
NHs (n=354), by county
County Response rate (%) Long term care residents HCWs
Median number (range) Median VC (range) Median number (range) Median VC (range
Akershus 21/66 (31.8) 32 (22–130) 71.4 (19.2-88.9) 65 (30–395) 0 (0 – 14.7)
Aust Agder 14/30 (46.7) 33 (8–66) 60.6 (0–100) 58 (33–150) 0 (0 – 6.3)
Buskerud 12/45 (26.7) 40 (20–108) 61.3 (15.4-91.9) 54 (17–400) 0 (0 – 9.6)
Finnmark 19/29 (65.5) 16 (6–40) 75.0 (18.8-100) 35 (17–85) 0 (0 – 29.4)
Hedmark 16/39 (41.0) 42 (23–110) 59.7 (22.7-100) 74 (35–247) 0 (0 – 3.0)
Hordaland 34/86 (39.5) 33 (9–143) 69.5 (25.0-100) 55 (15–300) 0.3 (0 – 22.2)
Møre og Romsdal 27/67 (40.3) 28 (5–76) 79.3 (28.1-100) 49 (12–110) 0 (0 – 18.2)
Nordland 22/74 (29.7) 29 (9–83) 66.7 (10.7-100) 60 (15–140) 2.5 (0 – 42.9)
Nord-Trøndelag 15/36 (41.7) 32 (8–86) 70.0 (18.5-92.1) 50 (22–200) 0 (0 – 5.7)
Oppland 11/39 (28.2) 40 (25–81) 54.8 (0–100) 90 (55–154) 0 (0 – 3.0)
Oslo 20/58 (34.5) 73 (11–168) 70.8 (37.5-100) 110 (16–400) 1.7 (0 – 8.6)
Rogaland 38/72 (52.8) 31 (1–120) 83.3 (0–100) 70 (15–300) 0 (0 – 53.3)
Sogn og Fjordane 16/34 (47.1) 33 (16–68) 77.0 (29.4-98.1) 60 (24–110) 4.4 (0 – 25.0)
Sør-Trøndelag 25/56 (44.6) 34 (13–91) 69.1 (27.7-100) 50 (25–158) 0 (0 – 33.3)
Telemark 11/30 (36.7) 38 (14–74) 71.4 (44.4-93.3) 60 (35–140) 0 (0 – 28.6)
Troms 12/43 (27.9) 28 (8–76) 74.5 (35.2-100) 59 (19–220) 0 (0 – 22.2)
Vest Agder 10/33 (30.3) 22 (6–106) 82.6 (58.3-100) 35 (20–170) 0 (0 – 13.8)
Vestfold 13/34 (38.2) 42 (12–80) 63.2 (40.0-93.3) 68 (39–195) 0 (0 – 6.1)
Østfold 19/39 (48.7) 51 (14–121) 77.7 (5.4-100) 110 (25–170) 0 (0 – 16.7)
* The true denominator is not known; the figures underestimate the true coverage, see Discussion.
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counties, the median NH VC was above 75%, including
one county with a VC of 83.3% (range 0-100) (Figure 2).
We did not find an association between the response
rate by county and vaccination coverage among residents
(Spearman rank test; rho 0.35; P = 0.15).
For HCWs, the median vaccination coverage was 0%
(range 0-100) (Table 1), with 214 (60%) NHs reporting
that none of their HCWs was vaccinated.Figure 1 Distribution of NHs in percentile vaccination coverage.)Financing influenza vaccination for HCWs
Of the 354 responding NHs, 165 (46.6%) provided informa-
tion on vaccination cost for HCWs. The vaccination was
free of charge in 143 (86.7%) NHs [median vaccination
coverage for employees free of charge 3.6% (min 0, max
53.3%)] while in 22 NHs employees had to pay for their
own influenza vaccination [median vaccination coverage
for employees who had to pay 3.6% (min 0, max 13.3%;
P = 0.47)]. The price varied between 1.50-25 Euros.Vaccination promotion
Of the 354 participating NHs, 316 (89.3%) answered that
they had performed an annual vaccination campaign,
38 did not promote annual vaccination campaigns or
the issue was unknown to them. Median VC for HCWs
in the NHs having an annual vaccination campaign was
0% (range 0-53), compared to when they did not have
an annual vaccination campaign 0% (range 0-12); the
distributions in the two groups differed significantly
(Mann–Whitney U, P = 0.006 two tailed). Our data
showed no difference between the VC of residents in
NHs with an annual vaccination campaign (median
72.4) and those without a vaccination campaign (median
68.5; P = 0.27).
Figure 2 Median vaccination coverage among residents per NH in % for each county.
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To the best of our knowledge, this is the first study to
aim at providing data on VC for seasonal influenza
vaccine among residents and HCWs in Norwegian
NHs.
In around half of the NHs, VC for seasonal influenza
vaccination among residents was below the 75% recom-
mended by WHO and laid down in National guidelines.
However, the VC of NH residents was markedly higher
than that in the general population above 65 years of age
[8]. This may reflect both the impact of the vaccination
recommendations’ specifically focusing on NH resi-
dents and awareness of vaccination of residents as an
important infection control measure. There are, how-
ever, still NHs with no residents vaccinated; thus a
substantial effort is still required in order to reach the
overall target of 75%.
Vaccination of HCWs has been shown to play an im-
portant role in controlling transmission of influenza to
residents [5]. A review from the Norwegian Knowledge
Center for the Health Services came to the conclusion
that influenza vaccination in HCWs reduced the risk of
acquiring influenza- like illness in residents by 50% [11].
On the other hand, a recent Cochrane review shows
that, when using laboratory confirmed influenza as an
endpoint [12], there is insufficient evidence to prove the
effect of vaccinating HCWs in relation to the transmis-
sion of influenza to residents. The Cochrane review,
however, did not take influenza like illness (ILI) and
all-cause mortality of residents into consideration, Theimpact of vaccinating HCWs has been discussed in
several articles. Potter [13] and Carman [14] took ILI
into consideration in their studies and found a signifi-
cant association between HCWs’ vaccination against
influenza and reduced rates of mortality in residents of
NHs, showing how important it is to vaccinate HCWs.
HCW absence from work owing to influenza is another
important issue and has been studied by several au-
thors [13,15-17]. These studies demonstrate reductions
in work-time lost owing to illness among vaccinated
HCWs. Moreover, in all of these studies, unvaccinated
HCWs with influenza continued to work while symp-
tomatic and may have infected residents. WHO also
recommends the vaccination of HCWs against sea-
sonal influenza in two other respects: One, as an
effective measure in decreasing the extent of seasonal
influenza and two, as a measure towards maintaining
an active workforce during influenza epidemics [5,6].
As studies in other European countries have shown
[18-22], we expected a low VC. Our results are mark-
edly lower than the results of the VENICE project on
influenza VC among all HCWs (12%), which is based
on a telephone survey of the general Norwegian popu-
lation and the numbers of influenza vaccines sold [8].
Most HCWs, however, are employed by hospitals,
which conduct more comprehensive infection control.
It is thus not unlikely that VC among HCWs in hospi-
tals is higher than in NHs. We therefore suppose that
our findings are more likely to reflect the actual VC
among HCWs in NHs.
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in the USA have already made seasonal influenza vaccin-
ation mandatory for HCWs with direct patient contact
[23,24]. In the Netherlands too, mandatory vaccination
programs are being discussed owing to low VC among
HCWs working in NHs. The authors of a Dutch study
concerning the ethical aspects of mandatory vaccination
conclude that NHs have a moral responsibility to imple-
ment vaccination programs with a view to getting their
HCWs to accept voluntary vaccination, but that this does
not exclude the possibility of introducing mandatory
vaccination if VC rates don’t rise [25].
The results of our study show that having to pay for the
vaccine does not affect the VC of HCWs while having
annual vaccination campaigns does lead to increases in
VC. In the Netherlands, vaccination campaigns have also
been found to increase VC while, interestingly, having to
pay for the vaccine as a HCW in a hospital actually
decreased VC [22].
The low VC among HCWs warrants studies to see
why they are so reluctant to be vaccinated. Specifically,
research into the reason for low VC in HCWs, as well as
into behavioral changes that are positively associated
with VC are needed. In the Netherlands, studies have
revealed a number of important, significant attitudes
held by HCWs in relation to influenza vaccination.
These include the responsibility not to harm patients,
the knowledge that the vaccine has high efficacy, and
the belief that they (HCWs) are in a high risk group in
relation to contracting influenza infection [22,25,26].
One limitation in our study is the low response rate.
We initially intended to reach all NHs through the generic
e-mail addresses of the municipalities, as we do not have
access to direct telephone and e-mail lists. More than half
of the NHs did not reply and any generalization from
the results should therefore be treated with caution.
While the e-mail modality is fast and convenient and
allows for the respondents to collect the requested data,
it may also result in lower response rates compared to
telephone modality interviews as undertaken in Venice
[8,27]. We did not, however, find an association be-
tween the response rate per county and the VC. All the
same, non-participating NHs could be vaccinating fewer
residents, resulting in an overestimation of the VC and
introducing bias towards “the best in the class”.
The extent to which NHs document vaccination is
unknown and we are unable to state if, and how much,
this influences our results.
Conclusion
From the results of our study, we are able to conclude that
the median influenza VC among residents of the partici-
pating NHs is not much lower than recommended. On
the other hand, influenza VC among HCWs in theparticipating NHs is exceedingly low. VC in HCWs was
significantly higher when NHs had an annual vaccin-
ation campaign. We recommend immediate measures
be implemented to increase VC in residents and, espe-
cially, in HCWs. These measures should encompass
vaccination campaigns and studies to identify potential
barriers to vaccination. In order to achieve more com-
prehensive and accurate data in future, a direct com-
munication channel with NHs should be established.
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